Search Results - ((testeae OR tester) OR ((est OR (testo OR gtested)) OR (tesis OR (tests OR enters)))) point~

Refine Results
  1. 30801
  2. 30802
  3. 30803
  4. 30804
  5. 30805
  6. 30806
  7. 30807
  8. 30808
  9. 30809
  10. 30810
  11. 30811

    Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by nocardia brasiliensis by Espinoza González, Nelly Alejandra, Welsh Lozano, Oliverio, De Torres, Noemi Waksman, Cavazos Rocha, Norma Cecilia, Ocampo Candiani, Jorge, Said Fernández, Salvador, Lozano Garza, Gerardo, Choi, Sung Hak, Vera Cabrera, Lucio

    Published 2008
    “…Two recently synthesized oxazolidinones: (R)-3-(4-(2-(2-methyltetrazol-5-yl)- pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (DA-7157) and its corresponding pro-drug (R)-3-(4-(2-(2-methyltetrazol-5-yl)-pyridin-5-yl)-3-fluorophenyl)- 2-oxo-5-oxazolidinyl) methyl disodium phosphate (DA-7218), have shown very good activity against several Gram positive bacteria, including Nocardia and Mycobacterium. …”
    Get full text
    Article
  12. 30812

    ESG impact on financial corporate performance and portfolio returns: evidence of Australia and Japan by Kazakakou Powaski, Margarita Chrissanthi, Daza Ordoñez, Carolina, Jáuregui Sánchez, Laura

    Published 2021
    “…Japan´s portfolio has positive returns but underperforms the benchmark. Low market capitalization portfolios with and without ESG outperform the higher capitalization portfolios. …”
    Get full text
    Article
  13. 30813
  14. 30814
  15. 30815
  16. 30816
  17. 30817
  18. 30818
  19. 30819
  20. 30820

Search Tools: